Overview

Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers

Status:
Recruiting
Trial end date:
2033-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to further study the pharmacokinetic characteristics of Chiauranib Capsule in Healthy Volunteers with High Fat Diet.
Phase:
Phase 1
Details
Lead Sponsor:
Chipscreen Biosciences, Ltd.
Collaborator:
H & J CRO International, Inc.
Treatments:
Chiauranib